What is Prestige Brand Holdings Inc?
, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
PBH · Verdict
Moderate reward · low risk
PBH stands out on cash flow and volatility, but watch the growth signal.
Based on 88% data coverage
PBH · Verdict
21% free-cash-flow margin
Top decile vs peers
19% net margin · 10% ROE
Interest covered 7.0×
Rev +1.5% CAGR · earnings +1.5%
Model-based scoring. For information only — not financial advice.
, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 3.38B, and a P/E ratio of 18.3x.
The scoring profile indicates limited reward potential at this time, with profitability and valuation offering the most support. Risk indicators are low, suggesting a relatively contained downside profile.
For informational purposes only. Not financial advice.